Air contamination in the sclerosing foam for the treatment of varicose veins

被引:3
作者
de Franciscis, S. [1 ,2 ]
Nobile, C. G. A. [3 ]
Larosa, E. [3 ]
Montemurro, R. [2 ]
Serra, R. [1 ,2 ]
机构
[1] Magna Graecia Univ Catanzaro, Int Res & Educ Program Clin & Expt Biotechnol, Interuniv Ctr Phlebolymphol CIFL, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Surg & Med Sci, I-88100 Catanzaro, Italy
[3] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy
关键词
Chronic venous disease; sclerotherapy; foam sclerotherapy; infectious disease; varicose veins; VENOUS DISORDERS; SCLEROTHERAPY; EFFICACY; TIME;
D O I
10.1177/0268355514565194
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Fluids and drugs formulated for intravenous infusion may potentially promote the growth of microorganisms that can cause infections. The aim of this study is to test the sterility of sclerosing foam. Methods Polidocanol was used for the production of the foam. The Tessari method was used in order to generate the foam. The preparation was carried out both in the operating theater and in an outpatient room. A validation test with microorganisms was also performed. Results The measurements showed no evident growth of microorganisms and in the validation tests the foam appeared to even display bacteriostatic and/or bactericide properties. Conclusions Sclerosing foam seems to be safe from a microbiological point of view.
引用
收藏
页码:96 / 100
页数:5
相关论文
共 20 条
  • [1] Angelillo IF, 1998, LETT APPL MICROBIOL, V27, P292, DOI 10.1046/j.1472-765X.1998.00430.x
  • [2] [Anonymous], 2005, European Pharmacopoeia, V5th edn
  • [3] Curran E., 2011, BR J NURS, V20, pS6
  • [4] Foam Sclerotherapy: Investigating the Need for Sterile Air
    De Roos, Kees-Peter
    Groen, Leon
    Leenders, Alexander C. A. P.
    [J]. DERMATOLOGIC SURGERY, 2011, 37 (08) : 1119 - 1124
  • [5] Dutch Working Party on Infection Prevention (WIP), 2006, CIRC MIN SURG INV PR
  • [6] Gobin JP, 2006, PHLEBOLOGIE, V59, P73
  • [7] Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: A randomised, double-blind trial with 2 year-follow-up. "The 3/1 study"
    Harnel-Desnos, C.
    Ouvry, P.
    Benigni, J. -P.
    Boitelle, G.
    Schadeck, M.
    Desnos, P.
    Allaert, F. -A.
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2007, 34 (06) : 723 - 729
  • [8] Kendler Michael, 2007, J Dtsch Dermatol Ges, V5, P648, DOI 10.1111/j.1610-0387.2007.06310.x
  • [9] Contamination of intravenous fluids: A continuing cause of hospital bacteremia
    Macias, Alejandro E.
    Huertas, Martha
    Ponce de Leon, Samuel
    Munoz, Juan M.
    Chavez, Alma R.
    Sifuentes-Osornio, Jose
    Romero, Carmen
    Bobadilla, Miriam
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2010, 38 (03) : 217 - 221
  • [10] Comparative risk of bloodstream infection in hospitalized patients receiving intravenous medication by open, point-of-care, or closed delivery systems
    Mercaldi, Catherine J.
    Lanes, Stephan
    Bradt, Jason
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (11) : 957 - 965